Korean Infectious Disease Research Institute and US Allergy and Infectious Disease Research Institute Join Hands for Vaccine and Treatment Research

Exchange of Letters of Intent for Cooperation in Vaccine and Treatment Research

[Image source=Yonhap News]

[Asia Economy Reporter Kim Ji-hee] The National Institute of Infectious Diseases at the Korea Disease Control and Prevention Agency announced on the 23rd that it exchanged a letter of intent for research cooperation in the fields of vaccines and therapeutics with the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health on the 18th.

The National Institute of Infectious Diseases and the U.S. National Institute of Allergy and Infectious Diseases have been promoting the exchange of letters of intent for joint infectious disease research between the two countries since the inauguration of the Biden administration, and completed the exchange in line with the recent Korea-U.S. summit. Through this letter of intent, both institutions have agreed to expand international joint research and researcher exchanges in the fields of vaccines and therapeutics.

In particular, the two institutions will prioritize research on vaccine development and therapeutics for emerging infectious diseases such as COVID-19. They also plan to jointly pursue research on tuberculosis vaccines and therapeutics, antibiotic resistance, and immunological studies related to infectious diseases.

Jang Hee-chang, director of the National Institute of Infectious Diseases, stated, "We will strengthen cooperation with the U.S. National Institute of Allergy and Infectious Diseases to accelerate the development of vaccines and therapeutics for emerging and unresolved infectious diseases," adding, "We will expand the domestic expert network and specify areas of cooperation between Korea and the U.S. to grow into a research institute capable of rapid response to new infectious diseases."

Kim Byung-guk, head of the Vaccine Clinical Research Division who has been promoting the exchange of the letter of intent, said, "The U.S. National Institute of Allergy and Infectious Diseases has high expectations for cooperative research and personnel exchanges with our newly established institute last year," and added, "This opportunity will greatly help strengthen the international capabilities of the National Institute of Infectious Diseases."

This content was produced with the assistance of AI translation services.